Cargando…
A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture
This study was performed to evaluate and compare the pharmacokinetic parameters between two dosage formulations of hesperidin and naringenin: mixture and tablet. Our objective was to determine that the flavonoid tablet does not significantly modify the pharmacokinetic parameters compared with the mi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780089/ https://www.ncbi.nlm.nih.gov/pubmed/35056705 http://dx.doi.org/10.3390/molecules27020391 |
_version_ | 1784637745287659520 |
---|---|
author | Araujo-León, Jesús Alfredo Ortiz-Andrade, Rolffy Hernández-Baltazar, Efrén Hernández-Núñez, Emanuel Rivera-Leyva, Julio César Yáñez-Pérez, Víctor Vazquez-Garcia, Priscila Cicero-Sarmiento, Carla Georgina Sánchez-Salgado, Juan Carlos Segura-Campos, Maira Rubí |
author_facet | Araujo-León, Jesús Alfredo Ortiz-Andrade, Rolffy Hernández-Baltazar, Efrén Hernández-Núñez, Emanuel Rivera-Leyva, Julio César Yáñez-Pérez, Víctor Vazquez-Garcia, Priscila Cicero-Sarmiento, Carla Georgina Sánchez-Salgado, Juan Carlos Segura-Campos, Maira Rubí |
author_sort | Araujo-León, Jesús Alfredo |
collection | PubMed |
description | This study was performed to evaluate and compare the pharmacokinetic parameters between two dosage formulations of hesperidin and naringenin: mixture and tablet. Our objective was to determine that the flavonoid tablet does not significantly modify the pharmacokinetic parameters compared with the mixture. For this study, we administered 161 mg/kg of either mixture (Mix-160) or tablet composed of hesperidin and by intragastric administration. Blood microsamples were collected from tail vein up to 24 h. Serum flavonoid extraction was performed by solid phase extraction and analyzed by LC-MS/MS of triple quadrupole (QqQ). Serum concentration vs. time plot showed that data fitted for a first-order model. The pharmacokinetic parameters were calculated by a noncompartmental model. The results showed that the absorption constant is higher than the elimination constant. The first concentration was found at five minutes, and minimal concentration at 24 h after administration, suggesting a enterohepatic recirculation phenomena and regulation of liver cytochromes’ activity. We did not find meaningful differences between the pharmacokinetic parameters of both samples. We concluded that tablet form did not interfere with the bioavailability of hesperidin and naringenin, and it could be a suitable candidate for developing a drug product. |
format | Online Article Text |
id | pubmed-8780089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87800892022-01-22 A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture Araujo-León, Jesús Alfredo Ortiz-Andrade, Rolffy Hernández-Baltazar, Efrén Hernández-Núñez, Emanuel Rivera-Leyva, Julio César Yáñez-Pérez, Víctor Vazquez-Garcia, Priscila Cicero-Sarmiento, Carla Georgina Sánchez-Salgado, Juan Carlos Segura-Campos, Maira Rubí Molecules Article This study was performed to evaluate and compare the pharmacokinetic parameters between two dosage formulations of hesperidin and naringenin: mixture and tablet. Our objective was to determine that the flavonoid tablet does not significantly modify the pharmacokinetic parameters compared with the mixture. For this study, we administered 161 mg/kg of either mixture (Mix-160) or tablet composed of hesperidin and by intragastric administration. Blood microsamples were collected from tail vein up to 24 h. Serum flavonoid extraction was performed by solid phase extraction and analyzed by LC-MS/MS of triple quadrupole (QqQ). Serum concentration vs. time plot showed that data fitted for a first-order model. The pharmacokinetic parameters were calculated by a noncompartmental model. The results showed that the absorption constant is higher than the elimination constant. The first concentration was found at five minutes, and minimal concentration at 24 h after administration, suggesting a enterohepatic recirculation phenomena and regulation of liver cytochromes’ activity. We did not find meaningful differences between the pharmacokinetic parameters of both samples. We concluded that tablet form did not interfere with the bioavailability of hesperidin and naringenin, and it could be a suitable candidate for developing a drug product. MDPI 2022-01-08 /pmc/articles/PMC8780089/ /pubmed/35056705 http://dx.doi.org/10.3390/molecules27020391 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Araujo-León, Jesús Alfredo Ortiz-Andrade, Rolffy Hernández-Baltazar, Efrén Hernández-Núñez, Emanuel Rivera-Leyva, Julio César Yáñez-Pérez, Víctor Vazquez-Garcia, Priscila Cicero-Sarmiento, Carla Georgina Sánchez-Salgado, Juan Carlos Segura-Campos, Maira Rubí A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture |
title | A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture |
title_full | A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture |
title_fullStr | A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture |
title_full_unstemmed | A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture |
title_short | A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture |
title_sort | pharmacokinetic study of mix-160 by lc-ms/ms: oral bioavailability of a dosage form of citroflavonoids mixture |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780089/ https://www.ncbi.nlm.nih.gov/pubmed/35056705 http://dx.doi.org/10.3390/molecules27020391 |
work_keys_str_mv | AT araujoleonjesusalfredo apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT ortizandraderolffy apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT hernandezbaltazarefren apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT hernandeznunezemanuel apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT riveraleyvajuliocesar apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT yanezperezvictor apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT vazquezgarciapriscila apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT cicerosarmientocarlageorgina apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT sanchezsalgadojuancarlos apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT seguracamposmairarubi apharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT araujoleonjesusalfredo pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT ortizandraderolffy pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT hernandezbaltazarefren pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT hernandeznunezemanuel pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT riveraleyvajuliocesar pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT yanezperezvictor pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT vazquezgarciapriscila pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT cicerosarmientocarlageorgina pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT sanchezsalgadojuancarlos pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture AT seguracamposmairarubi pharmacokineticstudyofmix160bylcmsmsoralbioavailabilityofadosageformofcitroflavonoidsmixture |